Showing results (121-130 of 226) with videos related to
Sort By:
Pageof 23
Blood|November 1, 2007
Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trialEdo Vellenga, Wim L J van Putten, Mars B van 't Veer, et al.European Journal of Nuclear Medicine and Molecular Imaging|February 14, 2026
A Lesion-adaptive Segmentation Approach for Tumor Delineation on FDG PET/CT in Diffuse Large B-cell Lymphoma PatientsGerben J C Zwezerijnen, Martijn W Heymans, Danielle van Assema, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2009
Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumesMarie L De Bruin, Judith Sparidans, Mars B van't Veer, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 6, 2021
Interobserver Agreement on Automated Metabolic Tumor Volume Measurements of Deauville Score 4 and 5 Lesions at Interim 18F-FDG PET in Diffuse Large B-Cell LymphomaGerben J C Zwezerijnen, Jakoba J Eertink, Coreline N Burggraaff, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2012
Dose-intensification in early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD14 trialBastian von Tresckow, Annette Plütschow, Michael Fuchs, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 22, 2021
18F-FDG PET Improves Baseline Clinical Predictors of Response in Diffuse Large B-Cell Lymphoma: The HOVON-84 StudyCoreline N Burggraaff, Jakoba J Eertink, Pieternella J Lugtenburg, et al.Nature Immunology|December 27, 2016
HIV-1 blocks the signaling adaptor MAVS to evade antiviral host defense after sensing of abortive HIV-1 RNA by the host helicase DDX3Sonja I Gringhuis, Nina Hertoghs, Tanja M Kaptein, et al.Hemasphere|November 15, 2019
Reduced-Intensity Chemotherapy in Patients With Advanced-Stage Hodgkin Lymphoma: Updated Results of the Open-Label, International, Randomised Phase 3 HD15 Trial by the German Hodgkin Study GroupAndreas Engert, Helen Goergen, Jana Markova, et al.Journal of Extracellular Biology|July 1, 2024
Towards IVDR-compliance by implementing quality control steps in a quantitative extracellular vesicle-miRNA liquid biopsy assay for response monitoring in patients with classic Hodgkin lymphomaEsther E E Drees, Nils J Groenewegen, Sandra A W M Verkuijlen, et al.Blood Cancer Journal|March 10, 2022
Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage: a nationwide, population-based study in the Netherlands, 1989-2018Müjde Durmaz, Otto Visser, Eduardus F M Posthuma, et al.Pageof 23